Buck Wealth Strategies LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Buck Wealth Strategies LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,747 shares of the healthcare conglomerate’s stock after acquiring an additional 3,571 shares during the period. Buck Wealth Strategies LLC’s holdings in UnitedHealth Group were worth $7,966,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. AMF Tjanstepension AB grew its stake in shares of UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares in the last quarter. Hudson Value Partners LLC increased its position in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares during the period. Brookstone Capital Management grew its holdings in UnitedHealth Group by 6.7% during the 3rd quarter. Brookstone Capital Management now owns 24,289 shares of the healthcare conglomerate’s stock worth $14,201,000 after acquiring an additional 1,529 shares in the last quarter. Hoxton Planning & Management LLC lifted its holdings in UnitedHealth Group by 30.8% during the third quarter. Hoxton Planning & Management LLC now owns 1,512 shares of the healthcare conglomerate’s stock worth $884,000 after buying an additional 356 shares during the period. Finally, Rockingstone Advisors LLC bought a new position in UnitedHealth Group in the third quarter worth about $291,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $539.50 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market cap of $496.49 billion, a PE ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The business has a 50-day simple moving average of $532.43 and a 200-day simple moving average of $564.77.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the company posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Bank of America cut their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.